AU2505697A - Novel oxazolidine derivatives, process for their production and medicaments containing them - Google Patents

Novel oxazolidine derivatives, process for their production and medicaments containing them

Info

Publication number
AU2505697A
AU2505697A AU25056/97A AU2505697A AU2505697A AU 2505697 A AU2505697 A AU 2505697A AU 25056/97 A AU25056/97 A AU 25056/97A AU 2505697 A AU2505697 A AU 2505697A AU 2505697 A AU2505697 A AU 2505697A
Authority
AU
Australia
Prior art keywords
production
medicaments containing
oxazolidine derivatives
novel oxazolidine
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU25056/97A
Other versions
AU722747B2 (en
Inventor
Liesel Doerge
Christos Tsaklakidis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19612827A external-priority patent/DE19612827A1/en
Priority claimed from DE1996154479 external-priority patent/DE19654479A1/en
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU2505697A publication Critical patent/AU2505697A/en
Assigned to ROCHE DIAGNOSTICS GMBH reassignment ROCHE DIAGNOSTICS GMBH Amend patent request/document other than specification (104) Assignors: BOEHRINGER MANNHEIM GMBH
Application granted granted Critical
Publication of AU722747B2 publication Critical patent/AU722747B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU25056/97A 1996-03-30 1997-03-26 Novel oxazolidine derivatives, process for their production and medicaments containing them Ceased AU722747B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19612827A DE19612827A1 (en) 1996-03-30 1996-03-30 New (pyridyl-piperidinyl)-(carboxy-cycloalkyl)cycloalkano:oxazolidinone
DE19612827 1996-03-30
DE1996154479 DE19654479A1 (en) 1996-12-27 1996-12-27 Oxazolidine derivs. to inhibit blood platelet aggregation,
DE19654479 1996-12-27
PCT/EP1997/001542 WO1997036899A1 (en) 1996-03-30 1997-03-26 Novel oxazolidine derivatives, process for their production and medicaments containing them

Publications (2)

Publication Number Publication Date
AU2505697A true AU2505697A (en) 1997-10-22
AU722747B2 AU722747B2 (en) 2000-08-10

Family

ID=26024325

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25056/97A Ceased AU722747B2 (en) 1996-03-30 1997-03-26 Novel oxazolidine derivatives, process for their production and medicaments containing them

Country Status (16)

Country Link
EP (1) EP0891359A1 (en)
JP (1) JP2000510445A (en)
KR (1) KR20000005117A (en)
CN (1) CN1219933A (en)
AR (1) AR006452A1 (en)
AU (1) AU722747B2 (en)
BR (1) BR9708475A (en)
CA (1) CA2250250A1 (en)
CZ (1) CZ305198A3 (en)
HU (1) HUP9901741A3 (en)
IL (1) IL126390A0 (en)
NO (1) NO984547L (en)
NZ (1) NZ332245A (en)
PL (1) PL329053A1 (en)
TR (1) TR199801961T2 (en)
WO (1) WO1997036899A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032486A1 (en) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
WO2002074762A1 (en) * 2001-03-15 2002-09-26 Takeda Chemical Industries, Ltd. Process for producing sulfone derivative
DE60229224D1 (en) * 2001-04-18 2008-11-20 Euro Celtique Sa Nociceptin Analogs
AU2003235895A1 (en) * 2002-05-09 2003-11-11 Mochida Pharmaceutical Co., Ltd. Process for producing 1-(4-pyridyl)-4-piperidone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122016D0 (en) * 1991-10-16 1991-11-27 Glaxo Group Ltd Chemical compounds
TW221996B (en) * 1991-11-14 1994-04-01 Glaxo Group Ltd
AU3351293A (en) * 1992-01-21 1993-08-03 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
DK0623615T3 (en) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhesion receptor antagonists
DE19524765A1 (en) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh New oxazolidinone derivatives, processes for their preparation and medicaments containing these compounds

Also Published As

Publication number Publication date
NO984547L (en) 1998-11-30
KR20000005117A (en) 2000-01-25
NZ332245A (en) 2000-03-27
CZ305198A3 (en) 1999-02-17
AR006452A1 (en) 1999-08-25
AU722747B2 (en) 2000-08-10
CA2250250A1 (en) 1997-10-09
HUP9901741A3 (en) 2000-03-28
BR9708475A (en) 1999-04-13
TR199801961T2 (en) 1999-01-18
IL126390A0 (en) 1999-05-09
JP2000510445A (en) 2000-08-15
CN1219933A (en) 1999-06-16
PL329053A1 (en) 1999-03-01
NO984547D0 (en) 1998-09-29
WO1997036899A1 (en) 1997-10-09
EP0891359A1 (en) 1999-01-20
HUP9901741A2 (en) 1999-09-28

Similar Documents

Publication Publication Date Title
AU1231697A (en) Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
AU694647B2 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
AU6526190A (en) 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds
AU1925197A (en) 4-amino-pyrimidine derivates, medicaments containing these compounds, their use and process for their production
HUT70848A (en) 1-aminoethyl-indol derivatives, process for production thereof and pharmaceutical compositions comprising them
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
AU2310795A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
HUP9602511A2 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
AU6594790A (en) Benzoxazine derivatives, pharmaceutical compositions containing them and processes for their production
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
HUP9602681A1 (en) Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
AU1369997A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
AU6197896A (en) Chromone derivative, process for preparing same and pharmaceutical composition
AU4278897A (en) 10,13,15-Trioxatricyclo(9.2.1.1.9.6)-Pentadecanone derivatives, method for the production thereof and medicaments containing these compounds
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
AU3027297A (en) New thiazolidinediones, process for preparing the same and medicaments containing the same
HUP9900105A3 (en) Momopiperazine derivatives, process for producing them and pharmaceutical compositions containing them
AU4920996A (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
AU5895996A (en) Basic cobalt(II) carbonates, process for the production thereof and the use thereof
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU4946896A (en) Novel bi-tryptaminic derivatives, preparation process and utilization as drugs
AU2505697A (en) Novel oxazolidine derivatives, process for their production and medicaments containing them
HUP9904603A3 (en) Vitamin d3 derivatives, medicaments containing the same and process for production thereof
HUP9800472A3 (en) New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired